{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T04:08:24Z","timestamp":1767154104109,"version":"build-2238731810"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-14572-1","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T15:14:46Z","timestamp":1754925286000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chimeric SF-25 monoclonal antibody as a targeted therapy for SLC3A2 in adult T-cell leukemia\/lymphoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Shinsuke","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Yan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Hanada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimiharu","family":"Uozumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satsuki","family":"Owatari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Haraguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Yoshimitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Ishitsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"14572_CR1","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1002\/ijc.22536","volume":"120","author":"H Yano","year":"2007","unstructured":"Yano, H. et al. Regulatory T-cell function of adult T-cell leukemia\/lymphoma cells. Int. J. Cancer 120, 2052\u20132057 (2007).","journal-title":"Int. J. Cancer"},{"key":"14572_CR2","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.1038\/sj.onc.1208968","volume":"24","author":"FA Proietti","year":"2005","unstructured":"Proietti, F. A., Carneiro-Proietti, A. B. F., Catalan-Soares, B. C. & Murphy, E. L. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24, 6058\u20136068 (2005).","journal-title":"Oncogene"},{"key":"14572_CR3","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/1097-0142(19890915)64:6<1290::AID-CNCR2820640620>3.0.CO;2-Z","volume":"64","author":"S Hanada","year":"1989","unstructured":"Hanada, S. et al. The prevalence of human T-cell leukemia virus type I infection in patients with hematologic and nonhematologic diseases in an adult T-cell leukemia-endemic area of Japan. Cancer 64, 1290\u20131295 (1989).","journal-title":"Cancer"},{"key":"14572_CR4","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","volume":"79","author":"M Shimoyama","year":"1991","unstructured":"Shimoyama, M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984\u201387). Br. J. Haematol. 79, 428\u2013437 (1991).","journal-title":"Br. J. Haematol."},{"key":"14572_CR5","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/j.bbmt.2019.05.027","volume":"25","author":"M Iqbal","year":"2019","unstructured":"Iqbal, M. et al. Efficacy of allogeneic hematopoietic cell transplantation in human T cell lymphotropic virus type 1-associated adult T cell leukemia\/lymphoma: Results of a systematic review\/meta-analysis. Biol. Blood Marrow Transplant. 25, 1695\u20131700 (2019).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"14572_CR6","doi-asserted-by":"publisher","first-page":"e517","DOI":"10.1016\/S1470-2045(14)70202-5","volume":"15","author":"K Ishitsuka","year":"2014","unstructured":"Ishitsuka, K. & Tamura, K. Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma. Lancet Oncol. 15, e517-526 (2014).","journal-title":"Lancet Oncol."},{"key":"14572_CR7","doi-asserted-by":"publisher","first-page":"7504","DOI":"10.1200\/JCO.2023.41.16_suppl.7504","volume":"41","author":"I Choi","year":"2023","unstructured":"Choi, I. et al. A phase 2 trial of CHOP with anti-CCR4 antibody mogamulizumab for elderly patients with CCR4-positive adult T-cell leukemia\/lymphoma. J. Clin. Oncol. 41, 7504\u20137504 (2023).","journal-title":"J. Clin. Oncol."},{"key":"14572_CR8","first-page":"6573","volume":"48","author":"H Takahashi","year":"1988","unstructured":"Takahashi, H. et al. In vivo localization of human colon adenocarcinoma by monoclonal antibody binding to a highly expressed cell surface antigen. Cancer Res. 48, 6573\u20136579 (1988).","journal-title":"Cancer Res."},{"key":"14572_CR9","doi-asserted-by":"publisher","first-page":"e002140","DOI":"10.1136\/jitc-2020-002140","volume":"9","author":"G Pellizzari","year":"2021","unstructured":"Pellizzari, G. et al. Immunotherapy using IgE or CAR T cells for cancers expressing the tumor antigen SLC3A2. J. Immunother. Cancer 9, e002140 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"14572_CR10","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.celrep.2017.10.082","volume":"21","author":"K Ikeda","year":"2017","unstructured":"Ikeda, K. et al. SLC3A2 mediates branched-chain amino-acid-dependent maintenance of regulatory T cells. Cell Rep. 21, 1824\u20131838 (2017).","journal-title":"Cell Rep."},{"key":"14572_CR11","unstructured":"Stanciu, L. A. & Djukanovi\u0107, R. T Cell Protocols: Development and Activation (ed. Kearse, K. P.) 133\u2013141 (Humana Press, 2000)."},{"key":"14572_CR12","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/0016-5085(95)90022-5","volume":"108","author":"H Takahashi","year":"1995","unstructured":"Takahashi, H., Nakada, T., Nakaki, M. & Wands, J. R. Inhibition of hepatic metastases of human colon cancer in nude mice by a chimeric SF-25 monoclonal antibody. Gastroenterology 108, 172\u2013182 (1995).","journal-title":"Gastroenterology"},{"key":"14572_CR13","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/S0016-5085(89)80019-8","volume":"96","author":"H Takahashi","year":"1989","unstructured":"Takahashi, H. et al. Radioimmunolocation of hepatic and pulmonary metastasis of human colon adenocarcinoma. Gastroenterology 96, 1317\u20131329 (1989).","journal-title":"Gastroenterology"},{"key":"14572_CR14","first-page":"506","volume":"54","author":"S Yarnold","year":"1994","unstructured":"Yarnold, S. & Fell, H. P. Chimerization of antitumor antibodies via homologous recombination conversion vectors. Cancer Res. 54, 506\u2013512 (1994).","journal-title":"Cancer Res."},{"key":"14572_CR15","doi-asserted-by":"publisher","first-page":"4220","DOI":"10.1073\/pnas.86.11.4220","volume":"86","author":"AF LoBuglio","year":"1989","unstructured":"LoBuglio, A. F. et al. Mouse\/human chimeric monoclonal antibody in man: kinetics and immune response. Proc. Natl. Acad. Sci. U S A 86, 4220\u20134224 (1989).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"14572_CR16","first-page":"5461","volume":"51","author":"MB Khazaeli","year":"1991","unstructured":"Khazaeli, M. B. et al. Pharmacokinetics and immune response of 131I-chimeric mouse\/human B72.3 (human gamma 4) monoclonal antibody in humans. Cancer Res. 51, 5461\u20135466 (1991).","journal-title":"Cancer Res."},{"key":"14572_CR17","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/S0140-6736(88)90588-0","volume":"2","author":"G Hale","year":"1988","unstructured":"Hale, G. et al. Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H. Lancet 2, 1394\u20131399 (1988).","journal-title":"Lancet"},{"key":"14572_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1056\/NEJMoa011795","volume":"346","author":"B Coiffier","year":"2002","unstructured":"Coiffier, B. et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N. Engl. J. Med. 346, 235\u2013242 (2002).","journal-title":"N. Engl. J. Med."},{"key":"14572_CR19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev.iy.09.040191.002325","volume":"9","author":"JV Ravetch","year":"1991","unstructured":"Ravetch, J. V. & Kinet, J. P. Fc receptors. Annu. Rev. Immunol. 9, 457\u2013492 (1991).","journal-title":"Annu. Rev. Immunol."},{"key":"14572_CR20","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1126\/science.8451642","volume":"259","author":"H Takahashi","year":"1993","unstructured":"Takahashi, H., Nakada, T. & Puisieux, I. Inhibition of human colon cancer growth by antibody-directed human LAK cells in SCID mice. Science 259, 1460\u20131463 (1993).","journal-title":"Science"},{"issue":"7","key":"14572_CR21","first-page":"509","volume":"1988","author":"SL Welles","year":"1994","unstructured":"Welles, S. L. et al. The distribution of T-cell subsets among HTLV-I carriers in Japan. J. Acquir. Immune. Defic. Syndr. 1988(7), 509\u2013516 (1994).","journal-title":"J. Acquir. Immune. Defic. Syndr."},{"key":"14572_CR22","first-page":"4862","volume":"57","author":"K Etoh","year":"1997","unstructured":"Etoh, K. et al. Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo. Cancer Res. 57, 4862\u20134867 (1997).","journal-title":"Cancer Res."},{"key":"14572_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1365-2141.1988.tb06185.x","volume":"68","author":"K Yamaguchi","year":"1988","unstructured":"Yamaguchi, K. et al. Polyclonal integration of HTLV-I proviral DNA in lymphocytes from HTLV-I seropositive individuals: An intermediate state between the healthy carrier state and smouldering ATL. Br. J. Haematol. 68, 169\u2013174 (1988).","journal-title":"Br. J. Haematol."},{"key":"14572_CR24","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1182\/blood.V84.9.3080.3080","volume":"84","author":"S Takemoto","year":"1994","unstructured":"Takemoto, S., Matsuoka, M., Yamaguchi, K. & Takatsuki, K. A novel diagnostic method of adult T-cell leukemia: Monoclonal integration of human T-cell lymphotropic virus type I provirus DNA detected by inverse polymerase chain reaction. Blood 84, 3080\u20133085 (1994).","journal-title":"Blood"},{"key":"14572_CR25","first-page":"224","volume":"78","author":"JM Debets","year":"1989","unstructured":"Debets, J. M., Ruers, T. J., van der Linden, M. P., van der Linden, C. J. & Buurman, W. A. Inhibitory effect of corticosteroids on the secretion of tumour necrosis factor (TNF) by monocytes is dependent on the stimulus inducing TNF synthesis. Clin. Exp. Immunol. 78, 224\u2013229 (1989).","journal-title":"Clin. Exp. Immunol."},{"key":"14572_CR26","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/j.1460-2075.1995.tb07096.x","volume":"14","author":"M Tanaka","year":"1995","unstructured":"Tanaka, M., Suda, T., Takahashi, T. & Nagata, S. Expression of the functional soluble form of human fas ligand in activated lymphocytes. Embo. J. 14, 1129\u20131135 (1995).","journal-title":"Embo. J."},{"key":"14572_CR27","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1084\/jem.187.8.1205","volume":"187","author":"P Schneider","year":"1998","unstructured":"Schneider, P. et al. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J. Exp. Med. 187, 1205\u20131213 (1998).","journal-title":"J. Exp. Med."},{"key":"14572_CR28","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.4049\/jimmunol.161.8.3957","volume":"161","author":"TJ Sayers","year":"1998","unstructured":"Sayers, T. J. et al. Molecular mechanisms of immune-mediated lysis of murine renal cancer: Differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells. J. Immunol. 161, 3957\u20133965 (1998).","journal-title":"J. Immunol."},{"key":"14572_CR29","doi-asserted-by":"publisher","first-page":"6658","DOI":"10.4049\/jimmunol.162.11.6658","volume":"162","author":"MJ Smyth","year":"1999","unstructured":"Smyth, M. J. et al. Perforin is a major contributor to NK cell control of tumor metastasis. J. Immunol. 162, 6658\u20136662 (1999).","journal-title":"J. Immunol."},{"key":"14572_CR30","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3109\/07388551.2016.1163323","volume":"37","author":"S Soleimanpour","year":"2016","unstructured":"Soleimanpour, S., Hassannia, T., Motiee, M., Amini, A. A. & Rezaee, S. A. R. Fc\u03b31 fragment of IgG1 as a powerful affinity tag in recombinant Fc-fusion proteins: Immunological, biochemical and therapeutic properties. Crit. Rev. Biotechnol. 37, 371\u2013392 (2016).","journal-title":"Crit. Rev. Biotechnol."},{"key":"14572_CR31","first-page":"124","volume":"25","author":"S Hanada","year":"1985","unstructured":"Hanada, S., Tsubai, F. & Namba, Y. The characteristics of T-cell lines derived from peripheral blood of patients with adult T-cell leukemia-lymphoma. Recent Adv. Res. 25, 124\u2013135 (1985).","journal-title":"Recent Adv. Res."},{"key":"14572_CR32","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S0140-6736(64)92345-1","volume":"1","author":"JV Pulvertaft","year":"1964","unstructured":"Pulvertaft, J. V. Cytology of burkitt\u2019s tumour (AFRICAN LYMPHOMA). Lancet 1, 238\u2013240 (1964).","journal-title":"Lancet"},{"key":"14572_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55\u201363 (1983).","journal-title":"J. Immunol. Methods"}],"updated-by":[{"DOI":"10.1038\/s41598-025-21843-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14572-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14572-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14572-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:11:56Z","timestamp":1759320716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14572-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14572"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-14572-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"15 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-025-21843-4","URL":"https:\/\/doi.org\/10.1038\/s41598-025-21843-4","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29379"}}